Blog

EpiVax Awarded New “Innovation Voucher”

Accelerating the Development of a Game Changing Cancer Therapy PROVIDENCE, R.I., Aug. 3, 2017 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") today announced it received funding from the Rhode Island Commerce Corporation to accelerate the development of personalized cancer...

read more

Tregitope Takes a Step Toward the Clinic

EpiVax Signs First Commercial License for Tregitope Technology PROVIDENCE, R.I., April 25, 2017 - Providence-based biotechnology company EpiVax, Inc. ("EpiVax") has licensed its novel immune-modulating technology to an undisclosed global pharmaceutical company, for...

read more